Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression.
about
Purification of the major histocompatibility complex class I transcription factor H2TF1. The full-length product of the nfkb2 geneKBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cellsHeterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma.N-myc suppresses major histocompatibility complex class I gene expression through down-regulation of the p50 subunit of NF-kappa B.Identification of human granzyme B promoter regulatory elements interacting with activated T-cell-specific proteins: implication of Ikaros and CBF binding sites in promoter activation.Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvantAbsence of HLA class I expression by Reed-Sternberg cells.Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter.HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons.Development of a Multicellular Three-dimensional Organotypic Model of the Human Intestinal Mucosa Grown Under MicrogravityImmunotherapy of MHC class I-deficient tumors.A sustained reduction in IkappaB-beta may contribute to persistent NF-kappaB activation in human endothelial cells.Metastatic melanoma and immunotherapyA dominant transcriptional silencer located 5' to the human T-cell receptor V beta 2.2 gene segment which is activated in cell lines of thymic phenotype.Downregulation of HLA class I expression by c-myc in human melanoma is independent of enhancer A.Antigenic Hsp70-peptide upregulate altered cell surface MHC class I expression in TAMs and increases anti-tumor function in Dalton's lymphoma bearing mice.Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.
P2860
Q24312701-2AC29B47-8694-420C-84D5-DCEC18420E4EQ28269339-30F374D0-069C-4081-A6A3-F2AAE8A6C2BBQ33827463-DBB095DD-D3E2-40BB-B09A-3C63C4B62C83Q34041262-05CDA526-53C9-4217-9B67-F67ADEDF475FQ34088346-F615752C-EFF6-4589-9D5E-6C58F27DE20AQ35080697-1E412B7F-1ABF-4A34-A34E-EBEB8EFFE063Q35833799-89723F59-EACB-4E71-A56D-4C7931BD9877Q36364703-0E6FDC46-697F-4702-9D88-19E5AA30F62CQ36646679-A079CAA9-16F6-4ECE-92CE-651D173D1727Q37274310-F2E3580F-3A0A-47FF-A349-8AD72CF3CC9EQ37808218-C4D61D6E-0B44-4B8A-845F-53348C9C7C4EQ38355620-FFCEDC1C-9234-462D-8807-66C4CCC29D65Q38901338-9F74691B-FC52-4B89-9A89-C43398E6DE08Q39716884-F7EEC6A2-8888-4A46-8D39-F9D387374BA9Q40405758-F64E42DF-A0FE-4B9A-85BD-BC208FC76252Q42180421-9399CD71-D92F-48F4-B44A-D0D6BC9978BEQ42937330-C7958945-E3ED-4F8B-ADE1-AF7628282853Q54796511-065E54C4-7E31-4FCD-A37F-885BB5606DFD
P2860
Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Altered binding of regulatory ...... ng class I antigen expression.
@en
type
label
Altered binding of regulatory ...... ng class I antigen expression.
@en
prefLabel
Altered binding of regulatory ...... ng class I antigen expression.
@en
P2093
P2860
P356
P1476
Altered binding of regulatory ...... ng class I antigen expression.
@en
P2093
Blanchet O
Kourilsky P
Zinszner H
P2860
P304
P356
10.1073/PNAS.89.8.3488
P407
P50
P577
1992-04-01T00:00:00Z